Text: S.139 — 114th Congress (2015-2016)All Information (Except Text)

Text available as:

Shown Here:
Public Law No: 114-63 (10/07/2015)

 
[114th Congress Public Law 63]
[From the U.S. Government Publishing Office]



[[Page 129 STAT. 549]]

Public Law 114-63
114th Congress

                                 An Act


 
To permanently allow an exclusion under the Supplemental Security Income 
     program and the Medicaid program for compensation provided to 
  individuals who participate in clinical trials for rare diseases or 
             conditions. <<NOTE: Oct. 7, 2015 -  [S. 139]>> 

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled, <<NOTE: Ensuring Access 
to Clinical Trials Act of 2015. 42 USC 1305 note.>> 
SECTION 1. SHORT TITLE.

    This Act may be cited as the ``Ensuring Access to Clinical Trials 
Act of 2015''.
SEC. 2. <<NOTE: 42 USC 1382a note.>>  ELIMINATION OF SUNSET 
                    PROVISION.

    Effective as if included in the enactment of the Improving Access to 
Clinical Trials Act of 2009 (Public Law 111-255, 124 Stat. 2640), 
section 3 of that Act is amended by striking subsection (e).

    Approved October 7, 2015.

LEGISLATIVE HISTORY--S. 139:
---------------------------------------------------------------------------

CONGRESSIONAL RECORD, Vol. 161 (2015):
            July 16, considered and passed Senate.
            Sept. 28, considered and passed House.

                                  <all>